SciELO - Scientific Electronic Library Online

 
vol.83 número1El trabajo de parto previo a la cesárea protege contra la taquipnea transitoria del recién nacido índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Archivos de Pediatría del Uruguay

versión On-line ISSN 1688-1249

Resumen

AGUIRRE, Mey et al. Síndrome de Cushing secundario a interacción medicamentosa ritonavir/fluticasona . Arch. Pediatr. Urug. [online]. 2012, vol.83, n.1, pp.21-25. ISSN 1688-1249.

Summary  We present 3 cases of children infected with human immunodeficiency virus (treated with ritonavir / lopinavir, zidovudine and lamivudine) and persistent asthma, and/or allergic rhinitis (treatment with inhaled fluticasone propionate or intranasal) that later have concomitant therapy, weight gain, moon face, and stretch marks on thighs. In case 1 the diagnosis did not achieve clinical laboratory confirmation. In cases 2 and 3, the serum cortisol and ACTH were consistent with adrenal suppression. In case 1 after discontinuation of fluticasone physical examination was normal at 6 months. In case 2 after stopping fluticasone clinical examination was normal at 6 months, no paraclinical performing. In case 3 to 6 months of ritonavir exchange of clinical regression and normalization of ACTH and cortisol levels was evident. This confirms iatrogenic Cushing's syndrome secondary to ritonavir drug interaction/fluticasone

Palabras clave : CUSHING SYNDROME; HIV INFECTIONS; ASTHMA; RITONAVIR-adverse effects; ADRENAL CORTEX HORMONES-adverse effects; DRUG INTERACTIONS.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons